Koninklijke Philips N.V.

PHG Healthcare Medical Devices

Koninklijke Philips N.V.’s revenue for fiscal 2025 (year ended December 2025) was $20.2 billion, up 3.47% from fiscal 2024.

Revenue
+0.55%
EPS
−85.0%
Free cash flow
+154.2%
Total debt
−4.96%

Quarter to September 2026, against a year earlier

30.29 0.22 −0.72%
Market cap
$29.8B
P/E
25.8×
Fwd P/E
11.2×
Dividend yield
3.33%
F-score
7/9
Altman Z
1.98
Beneish M
−2.68
Dividend safety
55/100
Sep '26 Jun '26 Mar '26 Dec '25 Older periods
P/E ratio
20.67 19.86 22.85 24.87

+8 more quarters

P/S ratio
1.16 1.26 1.28 1.27
P/FCF ratio
11.28 14.05 14.78 44.24
P/Operating CF
38.55 59.63 118.50 16.23
P/B ratio
1.79 1.95 1.95 2.07
EV/Sales
1.39 1.51 1.52 1.50
EV/EBITDA
9.23 9.19 10.26 10.50
EV/FCF
13.56 16.85 17.59 52.15
Current Ratio
1.33 1.26 1.32 1.32
Net Debt/EBITDA
10.12 4.51 8.34 5.15
Debt/Equity
0.60 0.55 0.60 0.63
Earnings Yield
4.84% 5.03% 4.38% 4.02%
Free Cash Flow Yield
8.86% 7.12% 6.76% 2.26%
Free Cash Flow per Share
0.45 0.27 0.03 1.46
Book value per Share
13.67 13.96 14.04 13.11
Free Cash Flow
440.20 259.07 32.77 1,384.61
EV/EBIT
16.04 15.71 17.93 18.79
Other line items

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026